Hyaluronic acid-based nanocomplexes have been developpend as novel drug-nanocarriers to treat myotonic dystrophy
Hyaluronic acid-based nanocomplexes as novel drug-nanocarriers to treat myotonic dystrophy
M. Repellin
;F. Carton;F. Boschi;M. Malatesta
2019-01-01
Abstract
Hyaluronic acid-based nanocomplexes have been developpend as novel drug-nanocarriers to treat myotonic dystrophy
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
3052-Article Text-20695-3-10-20190702.pdf
accesso aperto
Tipologia:
Versione dell'editore
Licenza:
Dominio pubblico
Dimensione
52.06 kB
Formato
Adobe PDF
|
52.06 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
